Leeds, United Kingdom

Neil Mackinnon

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Clariant Finance (Bvi) Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Mackinnon. Retrieved from https://idiyas.com/inventor/neil-mackinnon-3sc8j3fp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil Mackinnon: Innovator in Optical Brightening Agents

Introduction

Neil Mackinnon is a notable inventor based in Leeds, GB. He has made significant contributions to the field of optical brightening agents. His work has led to the development of innovative solutions that enhance the brightness of materials.

Latest Patents

Neil Mackinnon holds 1 patent related to optical brightening agents. This patent showcases his expertise and commitment to advancing technology in this area.

Career Highlights

Neil is currently employed at Clariant Finance (BVI) Limited, where he continues to innovate and develop new products. His role at the company allows him to apply his knowledge and skills in a practical setting.

Collaborations

Neil has collaborated with esteemed colleagues, including John Stuart Cowman and John Martin Farrar. These partnerships have contributed to the success of his projects and the advancement of their shared goals.

Conclusion

Neil Mackinnon is a dedicated inventor whose work in optical brightening agents has made a significant impact in his field. His contributions continue to influence the industry and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…